Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 21 | 2025 | 302 | 4.850 |
Why?
|
| Stroke Volume | 6 | 2025 | 122 | 1.490 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 122 | 1.070 |
Why?
|
| Patient Readmission | 3 | 2025 | 122 | 0.990 |
Why?
|
| Ventricular Function, Left | 3 | 2025 | 114 | 0.890 |
Why?
|
| Myocarditis | 2 | 2020 | 24 | 0.880 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2025 | 31 | 0.860 |
Why?
|
| Defibrillators, Implantable | 4 | 2025 | 39 | 0.730 |
Why?
|
| Primary Prevention | 3 | 2025 | 63 | 0.660 |
Why?
|
| Telemetry | 2 | 2010 | 14 | 0.630 |
Why?
|
| Myocardial Infarction | 2 | 2020 | 247 | 0.620 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 96 | 0.610 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2018 | 54 | 0.560 |
Why?
|
| Cardiovascular Diseases | 4 | 2025 | 749 | 0.540 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 539 | 0.530 |
Why?
|
| Humans | 46 | 2025 | 43102 | 0.530 |
Why?
|
| Cocaine-Related Disorders | 1 | 2018 | 102 | 0.530 |
Why?
|
| Digoxin | 1 | 2017 | 10 | 0.530 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2017 | 14 | 0.530 |
Why?
|
| Hypertension | 7 | 2024 | 835 | 0.490 |
Why?
|
| Risk Factors | 12 | 2024 | 3994 | 0.490 |
Why?
|
| Middle Aged | 25 | 2025 | 12222 | 0.480 |
Why?
|
| Dyslipidemias | 1 | 2016 | 48 | 0.480 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 89 | 0.460 |
Why?
|
| Medicaid | 1 | 2017 | 143 | 0.460 |
Why?
|
| Tachycardia, Ventricular | 2 | 2025 | 15 | 0.450 |
Why?
|
| Quality of Life | 1 | 2020 | 616 | 0.440 |
Why?
|
| Atherosclerosis | 1 | 2016 | 169 | 0.420 |
Why?
|
| Healthcare Disparities | 3 | 2023 | 590 | 0.400 |
Why?
|
| United States | 10 | 2025 | 5205 | 0.390 |
Why?
|
| Disease Management | 2 | 2025 | 70 | 0.380 |
Why?
|
| Coronary Angiography | 4 | 2024 | 96 | 0.360 |
Why?
|
| Aged | 17 | 2025 | 8214 | 0.360 |
Why?
|
| Electrocardiography | 3 | 2011 | 185 | 0.350 |
Why?
|
| Aortic Coarctation | 1 | 2011 | 1 | 0.340 |
Why?
|
| Thrombosis | 2 | 2003 | 81 | 0.340 |
Why?
|
| Primary Health Care | 3 | 2023 | 380 | 0.330 |
Why?
|
| Female | 24 | 2025 | 24698 | 0.330 |
Why?
|
| Male | 22 | 2025 | 23409 | 0.320 |
Why?
|
| Time Factors | 4 | 2024 | 1857 | 0.320 |
Why?
|
| Hospitalization | 4 | 2017 | 485 | 0.320 |
Why?
|
| Patient Admission | 1 | 2010 | 50 | 0.320 |
Why?
|
| Heart Diseases | 2 | 2009 | 112 | 0.310 |
Why?
|
| Practice Guidelines as Topic | 5 | 2021 | 223 | 0.310 |
Why?
|
| Adult | 15 | 2024 | 13872 | 0.300 |
Why?
|
| Incidence | 4 | 2024 | 1078 | 0.300 |
Why?
|
| Societies, Medical | 2 | 2025 | 74 | 0.280 |
Why?
|
| Prognosis | 5 | 2025 | 861 | 0.280 |
Why?
|
| Patient Selection | 2 | 2025 | 205 | 0.270 |
Why?
|
| Risk Assessment | 5 | 2024 | 863 | 0.270 |
Why?
|
| Clinical Trials as Topic | 2 | 2025 | 259 | 0.260 |
Why?
|
| Pulmonary Edema | 1 | 2007 | 12 | 0.260 |
Why?
|
| Cultural Diversity | 2 | 2025 | 193 | 0.250 |
Why?
|
| Coronary Vessels | 2 | 2011 | 92 | 0.250 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 236 | 0.250 |
Why?
|
| Retrospective Studies | 5 | 2021 | 2544 | 0.240 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2003 | 23 | 0.240 |
Why?
|
| Treatment Outcome | 4 | 2018 | 1604 | 0.230 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2025 | 42 | 0.230 |
Why?
|
| Consensus | 1 | 2025 | 48 | 0.230 |
Why?
|
| Georgia | 5 | 2025 | 192 | 0.220 |
Why?
|
| Shock, Cardiogenic | 1 | 2004 | 10 | 0.220 |
Why?
|
| Heart Block | 1 | 2004 | 4 | 0.220 |
Why?
|
| Aortic Diseases | 2 | 2024 | 34 | 0.220 |
Why?
|
| Cardiac Tamponade | 1 | 2004 | 6 | 0.220 |
Why?
|
| American Heart Association | 1 | 2023 | 24 | 0.210 |
Why?
|
| Health Facilities | 1 | 2023 | 32 | 0.210 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 163 | 0.200 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2004 | 203 | 0.190 |
Why?
|
| Troponin T | 1 | 2022 | 10 | 0.190 |
Why?
|
| Troponin I | 1 | 2022 | 18 | 0.190 |
Why?
|
| Pulmonary Embolism | 1 | 2003 | 38 | 0.190 |
Why?
|
| Cause of Death | 2 | 2024 | 186 | 0.180 |
Why?
|
| Protein S Deficiency | 1 | 2001 | 1 | 0.170 |
Why?
|
| Protein C Deficiency | 1 | 2001 | 1 | 0.170 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2021 | 14 | 0.170 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 719 | 0.170 |
Why?
|
| Stroke | 1 | 2024 | 340 | 0.160 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 638 | 0.140 |
Why?
|
| Arteriosclerosis | 1 | 1998 | 43 | 0.140 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 518 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2011 | 45 | 0.140 |
Why?
|
| Prevalence | 3 | 2016 | 1612 | 0.140 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 238 | 0.130 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 166 | 0.130 |
Why?
|
| Drug Utilization Review | 1 | 2017 | 7 | 0.130 |
Why?
|
| Propensity Score | 1 | 2017 | 59 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2025 | 1600 | 0.130 |
Why?
|
| Health Services Accessibility | 3 | 2024 | 706 | 0.130 |
Why?
|
| Academic Medical Centers | 2 | 2023 | 76 | 0.130 |
Why?
|
| Age Factors | 2 | 2016 | 1154 | 0.130 |
Why?
|
| Odds Ratio | 2 | 2016 | 587 | 0.120 |
Why?
|
| Cost-Benefit Analysis | 2 | 2025 | 179 | 0.120 |
Why?
|
| Young Adult | 2 | 2017 | 5080 | 0.120 |
Why?
|
| Comorbidity | 2 | 2016 | 737 | 0.110 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 263 | 0.110 |
Why?
|
| Urban Population | 2 | 2010 | 374 | 0.110 |
Why?
|
| Logistic Models | 2 | 2016 | 1009 | 0.110 |
Why?
|
| Multicenter Studies as Topic | 2 | 2025 | 61 | 0.110 |
Why?
|
| Disease Progression | 1 | 2017 | 667 | 0.110 |
Why?
|
| Medicare | 1 | 2017 | 332 | 0.100 |
Why?
|
| Blood Pressure | 4 | 2011 | 666 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 278 | 0.100 |
Why?
|
| New York City | 2 | 2006 | 288 | 0.100 |
Why?
|
| Aged, 80 and over | 4 | 2011 | 2853 | 0.090 |
Why?
|
| Registries | 3 | 2025 | 437 | 0.090 |
Why?
|
| Heart Failure, Systolic | 1 | 2011 | 4 | 0.090 |
Why?
|
| Aortography | 1 | 2011 | 10 | 0.090 |
Why?
|
| Exercise Therapy | 1 | 2011 | 87 | 0.090 |
Why?
|
| Health Policy | 2 | 2023 | 184 | 0.080 |
Why?
|
| Anticoagulants | 2 | 2003 | 122 | 0.080 |
Why?
|
| Organizational Policy | 1 | 2010 | 25 | 0.080 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2009 | 13 | 0.080 |
Why?
|
| Health Promotion | 2 | 2024 | 704 | 0.070 |
Why?
|
| Length of Stay | 1 | 2010 | 229 | 0.070 |
Why?
|
| Community Networks | 2 | 2006 | 107 | 0.070 |
Why?
|
| Echocardiography | 2 | 2011 | 167 | 0.070 |
Why?
|
| Health Literacy | 1 | 2010 | 130 | 0.070 |
Why?
|
| Exercise | 1 | 2013 | 692 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 20 | 0.060 |
Why?
|
| Radionuclide Imaging | 1 | 2006 | 29 | 0.060 |
Why?
|
| Medical Audit | 1 | 2006 | 26 | 0.060 |
Why?
|
| Physical Examination | 1 | 2006 | 45 | 0.060 |
Why?
|
| Adolescent | 1 | 2017 | 6081 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2013 | 368 | 0.060 |
Why?
|
| Aorta, Abdominal | 1 | 2024 | 17 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 135 | 0.050 |
Why?
|
| Japan | 1 | 2025 | 348 | 0.050 |
Why?
|
| Medical Assistance | 1 | 2023 | 6 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2010 | 719 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 375 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 440 | 0.050 |
Why?
|
| Writing | 1 | 2023 | 42 | 0.050 |
Why?
|
| Research Design | 1 | 2025 | 385 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2005 | 243 | 0.050 |
Why?
|
| Minority Groups | 2 | 2025 | 690 | 0.050 |
Why?
|
| Hirudin Therapy | 1 | 2003 | 1 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2025 | 359 | 0.050 |
Why?
|
| Vena Cava, Inferior | 1 | 2003 | 7 | 0.050 |
Why?
|
| Heart Atria | 1 | 2003 | 29 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2005 | 208 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 269 | 0.050 |
Why?
|
| Heart | 1 | 2024 | 184 | 0.050 |
Why?
|
| Warfarin | 1 | 2003 | 67 | 0.050 |
Why?
|
| Mentors | 1 | 2023 | 145 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 310 | 0.040 |
Why?
|
| Exercise Test | 1 | 2001 | 74 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2001 | 31 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 287 | 0.040 |
Why?
|
| Transportation | 1 | 2021 | 27 | 0.040 |
Why?
|
| Home Care Services | 1 | 2021 | 37 | 0.040 |
Why?
|
| Social Work | 1 | 2021 | 53 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2001 | 123 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2021 | 182 | 0.040 |
Why?
|
| Autopsy | 1 | 1998 | 48 | 0.040 |
Why?
|
| Health Education | 1 | 2021 | 363 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 1234 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3156 | 0.030 |
Why?
|
| Acute Disease | 1 | 2016 | 155 | 0.030 |
Why?
|
| Chest Pain | 1 | 2011 | 49 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2010 | 90 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 549 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 358 | 0.020 |
Why?
|
| Social Support | 1 | 2010 | 445 | 0.020 |
Why?
|
| South Carolina | 1 | 2006 | 25 | 0.020 |
Why?
|
| North Carolina | 1 | 2006 | 127 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 59 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2005 | 29 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2005 | 162 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 75 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 224 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 249 | 0.010 |
Why?
|
| Alleles | 1 | 2005 | 352 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2005 | 161 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 455 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 263 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 734 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 863 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 1067 | 0.010 |
Why?
|